Jennifer Thorley
Jennifer Thorley
Mark E Molitch
Mark E Molitch
Central diabetes insipidus from a patient's perspective: management, psychological co-morbidities, and renaming of the condition: results from an international web-based survey [0.03%]
central diabetes insipidus患者视角的管理、心理共病及疾病名称变更：一项国际网络调查结果
Cihan Atila,Paul Benjamin Loughrey,Aoife Garrahy et al.
Cihan Atila et al.
Background: Central diabetes insipidus is a rare neuroendocrine condition. Data on treatment-associated side-effects, psychological comorbidities, and incorrect management are scarce. The aim of this study was to investig...
The Lancet Diabetes Endocrinology
The Lancet Diabetes Endocrinology
Talha Burki
Talha Burki
Polycystic ovary syndrome [0.03%]
多囊卵巢综合征
Anju E Joham,Robert J Norman,Elisabet Stener-Victorin et al.
Anju E Joham et al.
Polycystic ovary syndrome (PCOS) affects 5-18% of women, and is a reproductive, metabolic, and psychological condition with impacts across the lifespan. The cause is complex, and includes genetic and epigenetic susceptibility, hypothalamic ...
Efficacy and safety of tirzepatide monotherapy compared with dulaglutide in Japanese patients with type 2 diabetes (SURPASS J-mono): a double-blind, multicentre, randomised, phase 3 trial [0.03%]
托西 Stra试验：司他钠单药治疗与杜拉鲁肽治疗2型糖尿病日本患者的疗效和安全性：一项多中心、双盲、随机、III期临床试验
Nobuya Inagaki,Masakazu Takeuchi,Tomonori Oura et al.
Nobuya Inagaki et al.
Background: As the disease progresses, many patients with type 2 diabetes have difficulty in reaching treatment goals. We aimed to assess the efficacy and safety of tirzepatide, a novel GIP and GLP-1 receptor agonist, com...
Safety and efficacy of tirzepatide as an add-on to single oral antihyperglycaemic medication in patients with type 2 diabetes in Japan (SURPASS J-combo): a multicentre, randomised, open-label, parallel-group, phase 3 trial [0.03%]
日本2型糖尿病患者联合口服降糖药物添加 tirzepatide治疗的疗效和安全性Ⅲ期临床试验（SURPASS-J组合）
Takashi Kadowaki,Rina Chin,Akichika Ozeki et al.
Takashi Kadowaki et al.
Background: Due to potential ethnic differences in the pathophysiology of type 2 diabetes, new therapeutics need to be evaluated in Japanese patients. We aimed to assess the safety and glycaemic efficacy of tirzepatide as...